semaglutide approval mash 🔴We now have two FDA-approved drugs for MASLD/MASH: 🔸 Resmetirom (oral, THR-β agonist) 🔹 (weekly SC, GLP-1 RA) side-by-side comparison, courtesy of @rabataller #MASLD #MASH #FattyLiver @_ILTS_ @EASLedu @AASLDtweets @novonordisk Demystifying medications in a type

Targeting a specific area for fat loss is the realm of surgery, not medication

The platform functions less like a traditional social network and more like a distributed peer-support infrastructure for people actively navigating treatment and researching treatment options

However, when coadministered with GLP-140, GIP-085 was able to reduce kaolin consumption driven by GLP-1R activation and it also significantly attenuated GLP-140induced anorexia at 72 hours, resulting in a 7- 6-g significant attenuation of GLP-140induced body weight loss

Gradual dose escalation starting at 0.25 mg and increasing every 4 weeks significantly reduces side-effect severity and duration